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Abstract: We have previously shown that fatty acid oxidation (FAO) is
required for AMP-activated protein kinase (PRKA)-induced maturation in vitro.
In the present study, we have further investigated the role of this metabolic
pathway in hormone-induced meiotic maturation. Incorporating an assay with
3
H-palmitic acid as the substrate, we first examined the effect of PRKA
activators on FAO levels. There was a significant stimulation of FAO in
cumulus cell-enclosed oocytes (CEO) treated with 5-aminoimidazole-4carboxamide ribonucleotide (AICAR) and RSVA405. In denuded oocytes (DO),
AICAR stimulated FAO only in the presence of carnitine, the molecule that
facilitates fatty acyl CoA entry into the mitochondria. The carnitine
palmitoyltransferase 1 activator C75 successfully stimulated FAO in CEO. All
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three of these activators trigger germinal vesicle breakdown. Meiotic
resumption induced by follicle-stimulating hormone (FSH) or amphiregulin
was completely inhibited by the FAO inhibitors etomoxir, mercaptoacetate,
and malonyl CoA. Importantly, FAO was increased in CEO stimulated by FSH
and epidermal growth factor, and this increase was blocked by FAO inhibitors.
Moreover, compound C, a PRKA inhibitor, prevented the FSH-induced increase
in FAO. Both carnitine and palmitic acid augmented hormonal induction of
maturation. In a more physiological setting, etomoxir eliminated human
chorionic gonadotropin (hCG)-induced maturation in follicle-enclosed oocytes.
In addition, CEO and DO from hCG-treated mice displayed an etomoxirsensitive increase in FAO, indicating that this pathway was stimulated during
in vivo meiotic resumption. Taken together, our data indicate that hormoneinduced maturation in mice requires a PRKA-dependent increase in FAO.
Keywords: AMPK, fatty acid oxidation, meiotic resumption, oocyte
maturation, PRKA

Introduction
Mammalian oocytes are maintained in meiotic arrest at
prophase-I from the time of birth until puberty. Beginning at puberty,
a cohort of ovarian follicles undergoes growth and development to the
preovulatory stage, the number varying by species. During this time,
the oocytes attain meiotic competence, and, in response to the
preovulatory gonadotropin surge, resume meiosis. They complete
meiosis-I, extruding a polar body, and then arrest at metaphase-II, at
which stage they remain until fertilization. The entire sequence of
events from the resumption of meiosis up to metaphase-II arrest is
known as oocyte maturation.
Oocyte maturation is regulated by a number of different
molecules in the oocyte as well as the cumulus granulosa and mural
granulosa cells. The granulosa compartment of the follicle plays a key
role in maintaining the oocyte in prophase-I arrest. Thus, oocytes
removed from the follicle and cultured in suitable medium resume
meiosis spontaneously in the absence of gonadotropins, visually
evident by the loss of the nuclear envelope, called germinal vesicle
breakdown (GVB). Meiotic arrest is maintained by maintaining
elevated cAMP levels in the oocyte, which blocks the activation of
maturation promoting factor, responsible for triggering the
downstream events of meiosis, including GVB [1]. This cAMP-mediated
arrest is overcome by gonadotropin stimulation of the somatic
compartment that leads to phosphodiesterase-mediated degradation of
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cAMP. AMP, the end product of such degradation, is an activator of
AMP-activated protein kinase (AMPK; hereafter referred to as PRKA)
that acts as a fuel gauge and responds to a high AMP:ATP ratio by
turning off energy-consuming pathways and turning on energygenerating pathways [2, 3].
Activation of PRKA is essential for the resumption of meiotic
maturation in mouse oocytes [4–7]. Treatment of meiotically arrested
mouse oocytes with PRKA activators 5-aminoimidazole-4-carboxamide
ribonucleotide (AICAR) [8] or the resveratrol analog RSVA405 [9]
stimulates meiotic resumption in vitro [4, 10, 11]. On the other hand,
Compound C, a PRKA inhibitor [12], blocks both the activation of PRKA
and meiotic induction brought about by treatment with AICAR [4],
hormones [5], or stress [6, 7], implicating PRKA as an important
player in the mechanism(s) regulating meiotic induction.
Acetyl CoA carboxylase (ACAC), an important substrate of PRKA,
converts acetyl CoA to malonyl CoA, which plays two important roles in
lipid metabolism: 1) it acts as precursor in the synthesis of long-chain
fatty acids, and 2) it inhibits carnitine palmitoyltransferase 1 (CPT1),
the mitochondrial outer membrane enzyme that links a carnitine
moiety to a fatty acyl group to facilitate transport into mitochondria for
beta-oxidation [13] (see Fig. 1). PRKA phosphorylates ACAC at serine79 (mouse), resulting in its inactivation, and the resulting decrease in
malonyl CoA removes the impediment to mitochondrial fatty acid
transport and thereby facilitates fatty acid oxidation (FAO) [13]. Thus,
ACAC provides an important link between PRKA activation and FAO.

FIG. 1: Schematic of fatty acid oxidation and its regulation. Carnitine palmitoyl
transferase 1 (CPT1) catalyzes the rate-limiting step in fatty acid oxidation (FAO):
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exchange of the coenzyme A (CoA) moiety of fatty acyl with carnitine, forming fatty
acylcarnitine that is then transported into the mitochondrial matrix by a translocase.
CPT1 is allosterically inhibited by malonyl CoA, produced by carboxylation of acetyl
CoA via acetyl CoA carboxylase (ACAC). Malonyl CoA is also a precursor in the
synthesis of long chain fatty acids. ACAC is inactivated through phosphorylation by
AMP-activated protein kinase (PRKA; active state designated by asterisk) that results
in decreased malonyl CoA production and release from CPT1 inhibition. This facilitates
fatty acid entry into mitochondria, subsequent exchange of carnitine for CoA (driven
by carnitine palmitoyl transferase 2, or CPT2), and FAO. The various pharmacological
modulators used in this study are italicized. Dotted lines represent stimulation. AICAR
and RSVA405 are PRKA activators, whereas compound C is a PRKA inhibitor. Etomoxir,
like malonyl CoA, inhibits CPT1, while C75 activates this enzyme. Mercaptoacetate
blocks the first step in mitochondrial FAO.

Carbohydrates—particularly pyruvate and glucose—have
attracted more attention than lipids as potential energy sources for
mammalian oocyte maturation, and their utilization has formed the
basis for many culture medium formulations. Pyruvate is an important
substrate utilized directly by the oocyte [14–16], and, although the
oocyte is poorly equipped to metabolize glucose, this substrate is
crucial for meiosis and acquisition of developmental competence [17]
because the somatic follicular compartment readily metabolizes
glucose to pyruvate that is then made available to the oocyte [14, 18,
19]. Dramatic shifts in GVB in vitro can be achieved by manipulating
relative carbohydrate levels in the culture medium [20, 21]. Further
evidence of the importance of glucose stems from compromised oocyte
physiology in diabetic animals [22–25].
With so much support for carbohydrate involvement in oocyte
development, there has been less motivation to address lipid
metabolism, particularly in rodent oocytes. Rodents have been a
popular model system for oocyte maturation studies, but these
oocytes have a very low level of lipid when compared to other
mammals (e.g., 4 ng/oocyte in the mouse [26] versus 63 ng in the
cow, 89 ng in the sheep, and 161 ng in the pig [27]). It is not
surprising that lipids represent an important energy source for oocytes
from domestic species (reviewed by [28, 29]). One untested
speculation attempting to explain the disparity of lipid content between
species is the different amounts of time taken by embryos to implant
in the uterine wall and thus different needs of energy stores within the
oocyte [28]. In a study by Cetica et al. [30], the lipase activity in
bovine oocytes was found to increase during meiotic maturation,
whereas Ferguson and Leese [31] reported that methyl palmoxirate, a
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CPT1 inhibitor, decreased oxygen consumption in maturing bovine
oocytes and affected subsequent blastocyst development.
Despite the low levels of lipid in mouse oocytes, PRKA
involvement in oocyte maturation and its well-established regulation of
FAO led us to examine a possible role for FAO in meiotic induction in
mouse oocytes [32]. The results of this earlier study provided
compelling evidence that FAO plays an important role in PRKA-induced
GVB in mouse oocytes. Among our findings, AICAR-induced in vitro
maturation was blocked by inhibitors of FAO that include etomoxir,
malonyl CoA, and mercaptoacetate. Etomoxir works in a similar
fashion to that of malonyl CoA, by inhibiting CPT1-mediated fatty acid
transport into mitochondria [33], whereas mercaptoacetate inhibits
long chain acyl CoA dehydrogenase, thereby blocking the first step in
the beta-oxidation pathway [34]. On the other hand, stimulation of
oocytes with C75, a CPT1 activator [35], increased meiotic resumption
in vitro, and this stimulatory effect was not blocked by inhibiting PRKA,
suggesting that FAO stimulation can bypass PRKA inhibition.
Since our study, an important series of experiments has been
presented by Dunning and associates [36] that further implicates lipid
metabolism as an integral component of oocyte maturation in mice.
They demonstrated by radioisotopic assay etomoxir-sensitive oxidation
of fatty acids by cell-enclosed oocytes (CEO) and denuded oocytes
(DO) as well as a direct relationship between the extent of FAO during
oocyte maturation and developmental competence (similar findings
have been reported for cow [31] and pig [37] oocytes); moreover,
carnitine increased the cleavage percentage of one-cell embryos in the
absence of external carbohydrate or protein sources, indicating
utilization of internal lipid stores [36]. They extended these findings to
show carnitine stimulation of FAO associated with increased
developmental potential of oocytes grown in follicle culture [38]. Other
groups have reported similar beneficial effects of carnitine on oocytes
from a variety of species (e.g., [37–42]), which is consistent with
increased lipase activity during oocyte maturation [30]. Carnitine has
beneficial effects beyond fatty acid utilization, also providing protection
against reactive oxygen species [43]; however, results of experiments
measuring FAO and effects of FAO inhibitors suggest a significant
portion of its influence is through modulation of FAO. Manipulating FAO
by providing media supplements such as carnitine holds promise for
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improving developmental competence in oocytes matured in vitro
[44].
In the present study, we have incorporated a metabolic assay
for FAO to extend our work on meiotic induction, with special emphasis
on more physiological hormonal stimulation. To this end, we 1)
confirm the involvement of FAO in meiotic induction triggered by
pharmacological PRKA activation and 2) demonstrate that hormoneinduced maturation, whether occurring in vivo or in vitro, also requires
FAO.

Materials and Methods
Chemicals
Equine chorionic gonadotropin (eCG), human chorionic
gonadotropin (hCG), and follicle-stimulating hormone (FSH) were
purchased from the National Hormone and Peptide Program and Dr.
A.F. Parlow, whereas amphiregulin (AR) and epidermal growth factor
(EGF) were obtained from R&D Systems. AICAR was from Toronto
Research Chemicals, RSVA405 from ChemBridge, and Compound C
from Calbiochem (EMD Millipore). Tritiated palmitic acid and water
were purchased from PerkinElmer. All the other chemicals, including Lcarnitine, were supplied by Sigma-Aldrich.

Oocyte Isolation and Culture
C57BL/6JxSJL/J F1 mice were used for all the experiments. All
the work was carried out with the preapproval of the Marquette
University Institutional Animal Care and Use Committee. Nineteen- to
twenty-three-day-old females were primed with 5 IU (international
units) eCG and killed 48 h later by cervical dislocation. Ovaries were
dissected out and placed in a dish containing culture medium, and CEO
were isolated by puncturing large antral follicles with sterile 26 gauge
needles. The CEO were washed several times and distributed to tubes
containing 1 ml of appropriate medium or microwells of a 96-well plate
with a final medium volume of 100 μl, depending on the experiment
involved. The DO were obtained by repeated pipetting of CEO with a
small bore pipet to remove cumulus cells. For culture in tubes, Eagle
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minimum essential medium (MEM) containing L-glutamine and
supplemented with 0.23 mM sodium pyruvate, 26 mM sodium
bicarbonate, penicillin, streptomycin, and 3 mg/ml crystallized
lyophilized bovine serum albumin (BSA) was used. Tubes were gassed
with a humidified mixture of 5% CO2/5% O2/90% N2, capped and
sealed with parafilm, and incubated at 37°C in a water bath. For FAO
assay cultures in 96-well plates and for experiments testing the effect
of palmitic acid or carnitine on FSH-induced maturation, fatty acid-free
BSA was used. For cultures in 96-well plates (both FAO assays and
maturation experiments), the above medium was buffered with 12.5
mM HEPES and 15.5 mM sodium bicarbonate.

Follicle Culture
Ovaries from eCG-primed mice were transferred to a dish of
Leibovitz L-15 medium supplemented with 3 mg/ml BSA, and antral
follicles were dissected free using sterile 27 gauge needles. Follicles
were then washed in MEM/5% fetal bovine serum (FBS) and
transferred to 1ml of MEM/FBS in a 10 ml stoppered flask, gassed with
95% O2/5% CO2, capped, and incubated in a water-jacketed incubator
at 37°C with constant, gentle agitation for 3.5 hours.

Solubilization of Palmitic Acid
For experiments testing the effect of palmitic acid doses on FSHinduced resumption of maturation, BSA-bound palmitic acid was used
to enhance its solubility and reduce precipitation, and was prepared
using a method described by Kane [45]. Five-hundred mg of fatty
acid-free BSA was dissolved in 30 ml sterile water to which was added
23 mg palmitic acid in 1 ml of absolute ethanol. This mixture was
shaken well till clear, frozen overnight, and lyophilized.

FAO Assay
FAO was measured using a modification of the protocol
described by Dunning et al. [36]. All the cultures were carried out in a
volume of 100 μl in wells of a 96-well plate and contained 9 μCi 9,10[3H] palmitate, with cold palmitate added to bring the final
concentration to 0.3 mM. Medium also contained 3 mg/ml fatty acidBiology of Reproduction, Vol 89(2), No. 43 (August 1, 2013): pg. 1-9. DOI. This article is © Society for the Study of
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free BSA, 12.5 mM HEPES, 15.5 mM sodium bicarbonate, and, when
appropriate, stimulators or stimulators plus inhibitors of FAO. A 2×
solution of palmitate/BSA was first made by adding 250 μl 12 mg/ml
fatty acid-free BSA in sterile water, 36 μl 9,10-[3H] palmitate (specific
activity 32.4 Ci/mmol, 5 mCi in 1 ml ethanol), and 25 μl 24 mM cold
palmitate in ethanol to a plastic test tube and drying down at 55°C
under N2 gas. It was then resuspended in 1 ml warm BSA-free MEM
and maintained at 37°C in a water bath until use; 50 μl of this mixture
was placed in each microwell, to which was added 50 μl MEM/fatty
acid-free BSA (3mg/ml) containing the appropriate number of CEO or
DO and 2× concentration of milrinone, an inhibitor of oocyte-specific
phosphodiesterase, and appropriate FAO modulators. The 96-well
plates were transferred to a modular incubator, gassed with a
humidified mixture of 5% CO2/5% O2/90% N2 and placed in a 37°C
water-jacketed incubator. Following the culture, samples were
processed as described by Dunning et al. [36], and 0.5 ml of the final
supernatant was counted for each sample. Twenty-five CEO or 40 DO
per well were used for each experiment. Experiments were carried out
at least three times, with duplicate groups per treatment. For each
experiment, blanks were included that contained no tissue to
determine background counts that were then subtracted from the
radioactivity from each sample, and values were corrected for dilution
during processing, percent recovery, and dilution with cold palmitate.

Statistical Analysis
All the experiments were repeated at least three times, and
those involving oocyte maturation included at least 25 CEO or DO per
group per experiment. Percent GVB values were subjected to arcsine
transformation followed by ANOVA and Duncan multiple range test to
assess statistical significance, with a P value less than 0.05 considered
significant. Maturation data are plotted as mean percent GVB ± SEM.
FAO assay data were calculated as ratio of the treatment group
compared to the control milrinone group and were analyzed by ANOVA
followed by Duncan's multiple range test.
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Results
Pharmacological Activators of PRKA Induce Maturation
and Stimulate FAO
We have previously shown that the PRKA activators, AICAR and
RSVA405, stimulate meiotic maturation [10, 46] and that AICARinduced maturation is prevented by agents that block FAO [32]. These
results implicated FAO as an essential component of the meiotic
induction process. It was therefore important to establish that FAO
could indeed be demonstrated during meiotic induction triggered by
pharmacological activation of PRKA. To this end, we used an assay
reported by Dunning et al. [36] in which oxidation was determined by
the production of tritiated water from radiolabeled palmitic acid. Before
carrying out the FAO assays, we first established that meiotic induction
was observed under the conditions of the assay, that is, when oocytes
maintained in meiotic arrest with milrinone in 100 μl cultures within
96-well plates were stimulated with the appropriate meiotic inducer.
Under these conditions, AICAR and RSVA405 triggered GVB in CEO by
52% and 25%, respectively (Supplemental Fig. S1, available online at
www.biolreprod.org).
FAO assays were then carried out for CEO cultured in the
presence of carnitine, PRKA activator, or the two agents together.
Carnitine is a molecule that is bound to fatty acids at the outer
mitochondrial membrane by the action of CPT1 and helps facilitate
their transport into mitochondria, thereby promoting their oxidation
[13]. In the presence of carnitine alone, FAO was stimulated in CEO by
nearly 1.7- to 2.2-fold (Fig. 2, A and C). AICAR and RSVA405 also
stimulated oxidation, by 1.6- and 1.3-fold, respectively. Although the
stimulation by RSVA405 was not significant as determined using
ANOVA, it was by the paired t-test. The addition of carnitine to AICARor RSVA405-containing medium did not result in an additive effect
(Fig. 2, A and C). When DO were tested, AICAR stimulated GVB in the
microwells (Supplemental Fig. S1); however, neither carnitine nor
AICAR alone stimulated FAO, although the two agents together
increased FAO by 1.8-fold (Fig. 2B).
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FIG. 2. Pharmacological activators of PRKA and C75, a CPT1 activator, stimulate FAO in oocytes. For the
FAO assay, CEO (A, C) were maintained in meiotic arrest with 2 μM milrinone and cultured with or without 1
mM carnitine and/or 250 μM AICAR (A) or 1.5 μM RSVA405 (C) for 18 h. For assays with DO (B), oocytes
were cultured in 1 μM milrinone ± 1 mM carnitine ± 125 μM AICAR for 8 h. In D, FAO levels were measured
in CEO cultured in medium containing 2 μM milrinone ± 1 mM carnitine ± 25 μM C75. Groups with no
common letter are significantly different. The asterisk indicates a significant difference from the control, as
determined using the Student paired t-test (P = 0.004). The number of times each experiment was carried
out is given in parentheses: A (3); B and C (5); D (4).

Our laboratory has shown that C75, a CPT1 activator [35],
induces meiotic resumption [32]; herein, we confirmed that C75
stimulates meiotic resumption in 96-well plates (Supplemental Fig.
S1). As shown in Figure 2D, C75 stimulated FAO in CEO by 1.6-fold. In
this way, C75 stimulation of maturation was associated with an
increase in FAO, and its effect in combination with carnitine was not
additive.
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Hormone-Induced Resumption of Maturation Is
Accompanied by an Increase in FAO Levels and Blocked
by Inhibitors of CPT1 and FAO
We examined whether inhibitors of CPT1 and FAO affect FSHinduced maturation. CEO were cultured in tubes and maintained in
meiotic arrest in medium containing dibutyryl cAMP (dbcAMP), a cAMPmimicking agent [47], and FSH was added to induce maturation. To
these FSH-treated cultures were added increasing doses of etomoxir, a
pharmacological inhibitor of CPT1 [48], malonyl CoA, a physiological
inhibitor of CPT1 [49], and mercaptoacetate, a direct inhibitor of FAO
[34]. In control medium, only 13%–20% of the oocytes underwent
GVB, whereas FSH stimulated maturation by 44%–64%, and this
effect was reduced to control levels by all three inhibitors in a dosedependent fashion (Fig. 3, A–C).

FIG. 3. FSH-induced maturation is blocked by inhibitors of FAO and accompanied by
increased FAO. In A–C, CEO were cultured in medium containing 300 μM dbcAMP ±0.1
μg/ml FSH and exposed to different doses of etomoxir (A), mercaptoacetate (B), or
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malonyl CoA (C) for 17–18 h and assessed for GVB. FAO levels were measured in CEO
cultured in 2 μM milrinone ± 0.1 μg/ml FSH for 18 h in the presence or absence of 1
mM carnitine (D), an FAO inhibitor (etomoxir, mercaptoacetate, or malonyl CoA) (E),
or 2.5 μM compound C, a PRKA inhibitor (F). In E, concentrations of FAO inhibitors are
in millimolar. Groups with no common letter are significantly different. The number of
times each experiment was carried out is given in parentheses: A–D (3); E (6); F (4).

We also carried out assays to investigate the effect of FSH on
FAO. As shown in Figure 3D, FSH alone stimulated FAO by 1.8-fold,
whereas carnitine and FSH together had an additive effect (FAO
increased by 2.6-fold). On the other hand, the three FAO inhibitors
each prevented the FSH-induced increase in FAO (Fig. 3E). Also, FSHstimulated FAO was blocked by Compound C (Fig. 3F), a PRKA
inhibitor [12] that blocks FSH-induced meiotic resumption [5].
EGF has also been shown to induce GVB in cultured mouse CEO
[50], and the maturation-inducing effect of FSH on the oocyte via
cumulus cells is mediated by EGF-like peptides such as AR [51–53].
Thus, we tested if the three FAO inhibitors suppress AR-induced GVB.
CEO were again cultured in tubes, maintained in meiotic arrest with
dbcAMP, and AR was added to stimulate maturation. As shown in
Figure 4, A–C, each inhibitor prevented AR-induced GVB. We also
tested if AR stimulated meiotic resumption in microwells
(Supplemental Fig. S1) but were unable to achieve meiotic induction
even at a concentration 4-fold higher than those used in the tubes
(data not shown). Thus, for FAO assays in microwells, EGF was used in
place of AR because EGF successfully stimulated maturation in the
wells (Supplemental Fig. S1). The EGF stimulation increased FAO by
1.6-fold, whereas together with carnitine, it had a greater stimulatory
effect (2.1-fold increase; Fig. 4D) that was not significantly different
from carnitine alone. The EGF-induced stimulatory effect was
completely blocked by etomoxir (Fig. 4E). To determine if oocyte
maturation was also affected, the action of etomoxir on EGFstimulated, dbcAMP-arrested CEO was tested in tubes. Like its effect
on other meiotic inducers, etomoxir significantly suppressed GVB in
EGF-treated oocytes at the concentration used in the FAO assay (Fig.
4F).
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FIG. 4. Meiotic induction by EGF-like peptides is associated with an increase in FAO
and blocked by inhibitors of FAO. In A–C, CEO cultured in medium containing 300 μM
dbcAMP were stimulated with 50 ng/ml amphiregulin (AR), and exposed to different
doses of etomoxir (A), mercaptoacetate (B), or malonyl CoA (C). In F, dbcAMParrested CEO were stimulated with 10 ng/ml EGF and treated with 100 μM etomoxir.
All groups were assessed for GVB 17–18 h later. FAO was measured in CEO cultured in
2 μM milrinone ± 10 ng/ml EGF in the presence or absence of 1 mM carnitine (D) or
100 μM etomoxir (E) for 18 h. Groups with no common letter are significantly
different. The number of times each experiment was carried out is given in
parentheses: A–C, E, and F (3); D (5).

Carnitine and Palmitic Acid Enhance Hormone-Induced
Meiotic Resumption
Because PRKA activation-induced meiotic resumption was
augmented by either carnitine or palmitic acid [32], we tested whether
the agents also promoted maturation in hormone-stimulated CEO.
These experiments were carried out in plastic tubes. The CEO were
maintained in meiotic arrest with dbcAMP, and different doses of
carnitine or palmitic acid were added in the presence or absence of
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FSH or AR. Both carnitine and palmitic acid significantly enhanced
meiotic resumption at 1 mM and 0.5 mM, respectively, in the presence
of FSH and AR, whereas they had no significant effect on GVB in the
absence of hormone (Fig. 5, A and B).

FIG. 5. Carnitine and palmitic acid enhance hormone-induced maturation. The CEO
were cultured in medium containing 300 μM dbcAMP ±10 ng/ml FSH or 1 ng/ml AR,
and treated with increasing concentrations of carnitine (A) or palmitic acid (B) and
scored for percent GVB 17–18 h later. An asterisk denotes a significant difference from
controls. The number of times each experiment was carried out is given in
parentheses: A (3); B (4).

Human Chorionic Gonadotropin-Induced Meiotic
Resumption and Stimulation of FAO Is Blocked by
Etomoxir
Meiotic arrest in follicle-enclosed oocytes in culture is
maintained by the granulosa cells, and meiotic resumption requires
gonadotropin stimulation [54]. Therefore, follicle culture more closely
mimics the physiological system of oocyte maturation than isolated
oocyte-cumulus complexes, making it crucial to test the effect of FAO
inhibitors on oocyte maturation in follicle-enclosed, hCG-stimulated
oocytes. Follicles were cultured in inhibitor-free medium ± hCG, and
the effect of etomoxir was tested. After 3.5 h of culture, 13% of
control oocytes had undergone GVB, and hCG increased this number
to 90% (Fig. 6A). The addition of etomoxir completely blocked hCGstimulated maturation (14% GVB).
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FIG. 6. Human chorionic gonadotropin-induced meiotic resumption and stimulation of
FAO are blocked by etomoxir. In A, antral follicles from eCG-primed mice were
cultured in the presence or absence of 5 IU/ml hCG ± 250 μM etomoxir, and GVB was
assessed 3.5 h later. For B and C, eCG-primed mice were injected with 5 IU hCG, and
CEO (B) or DO (C) were isolated 2 h post-hCG injection. FAO was measured after 16 h
culture in the presence of 2 μM (B) or 1 μM (C) milrinone ±100 μM etomoxir. Oocytes
from eCG-primed mice not injected with hCG were cultured as controls. Groups with
no common letter are significantly different. Each experiment was carried out four
times.

In addition, we measured FAO in oocytes isolated 2 h after hCG
injection to eCG-primed mice. Both CEO and DO retrieved from hCGinjected mice displayed higher levels of FAO compared to control
oocytes from primed mice not receiving hCG (1.9-fold increase), and
this response was blocked by etomoxir (Fig. 6, B and C).

Discussion
In a previous study [32], the use of PRKA and FAO activators
and inhibitors implicated FAO in the pharmacological stimulation of
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meiotic resumption in vitro. Herein, we have confirmed this finding by
carrying out FAO assays under similar experimental conditions. In
addition, we extended these experiments by examining the role of FAO
in hormone-induced GVB in both cumulus cell- and follicle-enclosed
oocytes. Whether maturation was stimulated by FSH, EGF-related
peptides, or hCG, two consistent findings were obtained: 1) meiotic
induction was blocked by FAO inhibitors, and(2) the hormones
stimulated FAO that was also sensitive to these inhibitors. Because the
resumption of maturation requires the action of PRKA, these results
provide compelling evidence that hormone-induced maturation in
mouse oocytes requires a chain of events involving PRKA stimulation
of FAO.
The PRKA activators AICAR and RSVA405 [8, 9] and the CPT1
activator C75 [35] all stimulate oocyte maturation. We have used a
radioisotopic FAO assay to show that this meiotic resumption is
associated with increased FAO, thereby confirming what was inferred
by the use of FAO-modulating agents in our earlier study [32].
Treatment of CEO with these activators led to stimulation of FAO;
however, in DO, AICAR stimulated FAO only when carnitine was
present. Carnitine, a crucial compound for shuttling long chain fatty
acids into mitochondria [13], also stimulated FAO by itself, but only in
CEO. The lack of its effect in DO is not due to an inability of the oocyte
to take up this compound because AICAR stimulation of FAO in DO was
carnitine-dependent.
Baseline levels of palmitate oxidation in control CEO and DO
maintained in meiotic arrest with milrinone were, on the average, 3.52
± 0.12 pmol/CEO/h (n = 99) and 0.06 ± 0.01 pmol/DO/h (n = 9),
respectively. These results indicate that the majority of FAO in CEO
resides within the cumulus oophorus, confirming the results of
Dunning et al. [36], and suggest that such cumulus cell activity may
play a role in meiotic regulation. Nevertheless, the direct effects of
FAO-modulating agents on FAO and meiotic maturation in DO ([32]
and data herein) demonstrate that stimulation of FAO within the
oocyte is essential for successful meiotic induction. It should be noted
that our levels of FAO are considerably higher than those reported by
Dunning et al. [36]. The reason for this is not clear but may be
influenced by type of culture medium, strain of mouse, or the degree
of palmitate solubilization.
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To further investigate the role of FAO in meiotic resumption, we
examined its participation in hormone-induced maturation. Etomoxir,
malonyl CoA, and mercaptoacetate were used to test the effect of FAO
inhibition on FSH- or AR-induced GVB. All three inhibitors completely
blocked induction of oocyte maturation by either hormone.
Furthermore, FSH and EGF caused a 1.7- and ∼1.5-fold stimulation of
FAO, respectively, that was reduced to control levels or below by FAO
inhibitors. The inability of AR to stimulate maturation in microwells was
unexpected but may be due to interaction of the hormone with the
plastic lining the microwells. Nevertheless, EGF effectively stimulated
GVB and FAO, and its effects were blocked by etomoxir. The addition
of carnitine to FSH-treated, but not EGF-treated, CEO produced an
additive effect on FAO. In this way, we demonstrated that hormonal
induction of maturation, like that achieved with PRKA activators, is
accompanied by increased FAO, whereas inhibition of FAO blocks
meiotic resumption. That carnitine and palmitic acid each significantly
enhanced FSH- and AR-induced maturation provides further support
for the participation of the FAO pathway in the mechanism(s)
controlling hormone-induced GVB in isolated CEO in vitro. Moreover,
because FSH-induced GVB requires activation of PRKA [5] and one of
the major effects of PRKA activation in cells is increased FAO [55], the
suppression of FSH-induced FAO by compound C indicates that active
PRKA was crucial for the increase in FAO by FSH.
While carnitine alone stimulates FAO in CEO, it does not induce
meiotic resumption, though it augments the meiosis-inducing action of
PRKA [32] and hormone stimulation. This suggests that FAO is
required, but by itself not sufficient, to induce GVB without stimulation
of PRKA or some other physiological response. Yet C75 alone
stimulates FAO to a similar extent but also triggers meiotic
resumption; furthermore, the fatty acid derivatives palmitoyl carnitine
and stearoyl carnitine also stimulate maturation, presumably by
feeding directly into the FAO pathway [32]. The reason for these
discrepancies is not clear, but possibilities include differing kinetics of
FAO activation by various modulating agents or limitations in our assay
in discriminating between subtle differences in FAO levels.
To increase the physiological relevance of our findings, we
tested follicle cultures and oocytes retrieved 2 h after hCG
administration to primed animals. We have previously shown that
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compound C blocks hCG-stimulated maturation in cultured mouse
follicles [56], thereby implicating PRKA. Thus, if PRKA also promotes
maturation in vivo via stimulation of FAO, hCG-induced intrafollicular
meiotic resumption should be sensitive to etomoxir treatment. Indeed,
the increase in maturation of follicle-enclosed oocytes brought about
by hCG was completely abrogated by etomoxir. And, as predicted, DO
and CEO from hCG-injected mice displayed 1.8- to 1.9-fold increases
in FAO that were inhibited by etomoxir. This finding is important
because the FAO increase occurred in response to an in vivo hormonal
stimulus and supports a role for FAO within the oocyte during
intrafollicular meiosis reinitiation.
In an important series of experiments, Dunning et al. [36, 38]
demonstrated etomoxir-sensitive hormonal regulation of FAO in mouse
CEO and DO and augmentation of this effect with carnitine. In
addition, they reported that modulation of FAO during follicular
development and oocyte maturation has a profound effect on
developmental competence. Interestingly, stimulation of FAO by
carnitine in the absence of exogenous energy sources provided
sufficient energy to drive embryo development. We have extended
these findings to show that FAO is an essential feature of meiotic
induction in mouse oocytes, whether it occurs in response to
pharmacological stimulation in vitro or is driven by hormones in vitro
or in vivo. Taken together, these data show a role for FAO throughout
oocyte maturation, beginning at the earliest stage of GVB and
extending to its completion at metaphase II. This conclusion parallels a
similar protracted role we have presented for PRKA during mouse
oocyte maturation [4, 5, 46, 54]. Based on the well-established
regulatory role for PRKA in FAO and our confirmation of this
relationship in the mouse oocyte, it is reasonable to propose that a
significant portion of PRKA influence on mouse oocyte physiology
during this period is mediated by FAO.
In conclusion, we have demonstrated an essential role for FAO
in the meiotic induction process in mouse oocytes. The fact that mouse
oocytes have very limited lipid reserves does not discount their
potential importance because only a small amount of energy-rich lipid
would be required to produce considerable energy via FAO to drive
meiotic resumption [28, 36]. Meiotic maturation in the mouse oocyte
requires PRKA activation [4] that leads to increased FAO ([32] and
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data herein) through the inactivation of ACAC located at the
mitochondrial outer membrane ([36]; see Introduction). This would
necessitate close proximity of lipid substrate to the mitochondria, and,
consistent with this idea, mitochondria/lipid droplet colocalization has
been demonstrated in the porcine oocyte [57]. It is possible that FAO
is necessary during meiotic induction because it supplies energy
and/or reducing equivalents at discrete locations within the oocyte that
are not well served by carbohydrate metabolizing pathways. FAO may
also remove fatty acids that would prove harmful to the oocyte or
suppress maturation if allowed to reach threshold levels (e.g., through
long-chain acetyl CoA synthetase-mediated palmitoylation reactions
[58]). The increased evidence for lipid participation in oocyte
development indicates that energy dynamics in this system are more
complex than previously thought. Future studies will hopefully shed
important light on the interplay between the different metabolic
pathways involved in energy dynamics during gametogenesis.
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Supplemental Figure S1. Effects of pharmacological and physiological stimulators on
meiotic maturation in the microwell culture system used for FAO assays. CEO were
cultured 17-18 h in 2 μM milrinone ± 250 μM AICAR, 1.5 μM RSVA405, 25 μM C75, 0.1
μg/ml FSH, 10 ng/ml EGF or 50 ng/ml amphiregulin and scored for GVB 18 h later. AICAR
stimulation was carried out twice, while all other treatments were tested three times and the
means for each treatment are presented.
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